多孔四氧化三铁靶向递送尼日利亚菌素诱导细胞焦亡联合光热疗法用于三阴型乳腺癌治疗的研究

doi:10.3969/j.issn.1009-976X.2021.03.007

摘要/Abstract

摘要： 目的探讨多孔四氧化三铁（Fe₃O₄）纳米粒子负载尼日利亚菌素（nigericin）联合光热疗法用于三阴型乳腺癌的治疗效果。方法对合成的多孔Fe₃O₄纳米粒子进行表征,负载尼日利亚菌素,使用含有200 μg/mL的Fe₃O₄@nigericin诱导4T1细胞焦亡,通过CCK8检测细胞杀伤能力,western blot验证焦亡效果。结果合成的Fe₃O₄形貌均一,光热转化性能好,负载尼日利亚菌素联合光热治疗具有更强的细胞杀伤能力（P<0.001）,诱导的焦亡效果更好（P<0.001）。结论多孔Fe₃O₄纳米粒子负载尼日利亚菌素联合光热疗法可以通过诱导焦亡对三阴型乳腺癌产生非常好的治疗效果,是三阴型乳腺癌的一种潜在的新型治疗手段。

关键词: 多孔四氧化三铁纳米粒子, 焦亡, 三阴型乳腺癌

Abstract: Objective To investigate the therapeutic effect of nigericin loaded with porous Fe₃O₄ nanoparticles combined with photothermal therapy for triple-negative breast cancer. Methods characterize synthesized porous Fe₃O₄ nanoparticles and loaded with nigericin. The Fe₃O₄@nigericin nanoparticle with 200 μg/ml was prepared to induce 4T1 pyroptosis. The cell killing ability was detected by CCK8, and the pyroptosis effect was verified by Western blot. Results The synthesized Fe₃O₄ showed uniform morphology and good photothermal conversion performance. The combination of loading nigericin and photothermal treatment showed stronger cell killing ability （P<0.001） and better pyroptosis effect （P<0.01）. Conclusion Porous Fe₃O₄ nanoparticles loaded with nigericin combining with photothermal therapy can produce very good therapeutic effect for triple-negative breast cancer by inducing pyroptosis, which is a potential new treatment method for triple-negative breast cancer.

Key words: porous Fe₃O₄ nanoparticles, pyroptosis, triple-negative breast cancer

中图分类号:

R737.9

江伟, 潘越, 姚和瑞, 胡海. 多孔四氧化三铁靶向递送尼日利亚菌素诱导细胞焦亡联合光热疗法用于三阴型乳腺癌治疗的研究[J]. 岭南现代临床外科, 2021, 21(03): 287-293.

JIANG Wei, PAN Yue, YAO He-rui, HU Hai. Porous ferroferric oxide targeted delivery of nigericin to induce pyroptosis combined with photothermal therapy for triple-negative breast cancer treatment[J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 287-293.

参考文献

[1] Goldhirsch A, Wood WC, Coates AS, et al.Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8): 1736-1747.
[2] Perou CM, Sørlie T, Eisen MB, et al.Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797): 747-752.
[3] Carey LA, Perou CM, Livasy CA, et al.Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study[J]. JAMA, 2006, 295(21): 2492-2502.
[4] Dent R, Trudeau M, Pritchard KI, et al.Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res, 2007, 13(15 Pt 1): 4429-4434.
[5] Haffty BG, Yang Q, Reiss M, et al.Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer[J]. J Clin Oncol, 2006, 24(36): 5652-5657.
[6] Zanganeh S, Hutter G, Spitler R, et al.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues[J]. Nat Nanotechnol, 2016, 11(11): 986-994.
[7] Ansari C, Tikhomirov GA, Hong SH, et al.Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy[J]. Small, 2014, 10(3): 566-575, 417.
[8] Asanuma T, Ono M, Kubota K, et al.Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease[J]. Gut, 2010, 59(2): 258-266.
[9] Johannsen M, Gneveckow U, Thiesen B, et al.Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution[J]. Eur Urol, 2007, 52(6): 1653-1661.
[10] Fan J, Lu J, Xu R, et al.Use of water-dispersible Fe(2)O(3) nanoparticles with narrow size distributions in isolating avidin[J]. J Colloid Interface Sci, 2003, 266(1): 215-218.
[11] Perez JM, Josephson L, O'Loughlin T, et al. Magnetic relaxation switches capable of sensing molecular interactions[J]. Nat Biotechnol, 2002, 20(8): 816-820.
[12] Zychlinsky A, Prevost MC, Sansonetti PJ.Shigella flexneri induces apoptosis in infected macrophages[J]. Nature, 1992, 358(6382): 167-169.
[13] Rathinam VA, Fitzgerald KA.Inflammasome Complexes: Emerging Mechanisms and Effector Functions[J]. Cell, 2016, 165(4): 792-800.
[14] Zhaolin Z, Guohua L, Shiyuan W, et al.Role of pyroptosis in cardiovascular disease[J]. Cell Prolif, 2019, 52(2): e12563.
[15] Shi J, Zhao Y, Wang K, et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015, 526(7575): 660-665.
[16] Evavold CL, Ruan J, Tan Y, et al. The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages [J]. Immunity, 2018, 48(1): 35-44.e6.
[17] Yang J, Liu Z, Wang C, et al.Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor[J]. Proc Natl Acad Sci U S A, 2018, 115(26): 6792-6797.
[18] Palacios-Macapagal D, Connor J, Mustelin T, et al.Cutting Edge: Eosinophils Undergo Caspase-1-Mediated Pyroptosis in Response to Necrotic Liver Cells[J]. J Immunol, 2017, 199(3): 847-853.
[19] Heneka MT, Kummer MP, Stutz A, et al.NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice[J]. Nature, 2013, 493(7434): 674-678.
[20] Zhang Y, Li X, Pitzer AL, et al.Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation[J]. Antioxid Redox Signal, 2015, 22(13): 1084-1096.
[21] Doitsh G, Galloway NL, Geng X, et al.Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection[J]. Nature, 2014, 505(7484): 509-514.
[22] Zhou B, Zhang JY, Liu XS, et al.Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis[J]. Cell Res, 2018, 28(12): 1171-1185.
[23] Pan H, Lin Y, Dou J, et al.Wedelolactone facilitates Ser/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis[J]. Cell Proliferation, 2020, 53(9): e12868.
[24] Liu F, Li W, Hua S, et al.Nigericin Exerts Anticancer Effects on Human Colorectal Cancer Cells by Inhibiting Wnt/β-catenin Signaling Pathway[J]. Mol Cancer Ther, 2018, 17(5): 952-965.
[25] Hegazy AM, Yamada D, Kobayashi M, et al.Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance[J]. J Biol Chem, 2016, 291(41): 21496-21509.
[26] Denkert C, Liedtke C, Tutt A, et al.Molecular alterations in triple-negative breast cancer-the road to new treatment strategies[J]. Lancet, 2017, 389(10087): 2430-2442.
[27] Cleator S, Heller W and Coombes RC Triple-negative breast cancer: therapeutic options[J]. Lancet Oncol, 2007, 8(3): 235-44.
[28] Salami S, Ramezani F, Aghazadeh T, et al.Impact of triple negative phenotype on prognosis and early onset of breast cancer in Iranian females[J]. Asian Pac J Cancer Prev, 2011, 12(3): 719-24.
[29] Umemura R, Ogawa H, Kan A.Low temperature sintering and microwave dielectric properties of (Mg3-xZnx)(VO4)2 ceramics[J]. J Eur Ceram Soc, 2006, 26(10-11): 2063-2068.
[30] Chu Z, Huang Y, Tao Q, et al.Cellular uptake, evolution, and excretion of silica nanoparticles in human cells[J]. Nanoscale, 2011, 3(8): 3291-9.
[31] Annangi B, Rubio L, Alaraby M, et al.Acute and long-term in vitro effects of zinc oxide nanoparticles[J]. Arch Toxicol, 2016, 90(9): 2201-2213.
[32] Hu W, Peng C, Lv M, et al.Protein corona-mediated mitigation of cytotoxicity of graphene oxide[J]. ACS Nano, 2011, 5(5): 3693-700.
[33] Lu S, Li X, Zhang J, et al.Dendrimer-Stabilized Gold Nanoflowers Embedded with Ultrasmall Iron Oxide Nanoparticles for Multimode Imaging-Guided Combination Therapy of Tumors[J]. Adv Sci (Weinh), 2018, 5(12): 1801612.
[34] Ge R, Liu C, Zhang X, et al.Photothermal-Activatable Fe(3)O(4) Superparticle Nanodrug Carriers with PD-L1 Immune Checkpoint Blockade for Anti-metastatic Cancer Immunotherapy[J]. ACS Appl Mater Interfaces, 2018, 10(24): 20342-20355.
[35] Yuan G, Yuan Y, Xu K, et al.Biocompatible PEGylated Fe₃O₄ nanoparticles as photothermal agents for near-infrared light modulated cancer therapy[J]. Int J Mol Sci, 2014, 15(10): 18776-18788.
[36] Zhou Z, He H, Wang K, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells [J]. Science, 2020, 368(6494):eaaz7548.
[37] Zhang Z, Zhang Y, Xia S, et al.Gasdermin E suppresses tumour growth by activating anti-tumour immunity[J]. Nature, 2020, 579(7799): 415-420.